Recursion Pharmaceuticals Stock (NASDAQ: RXRX) stock price, news, charts, stock research, profile.
Open | $10.100 |
Close | $9.970 |
Volume / Avg. | 5.442M / 7.061M |
Day Range | 9.940 - 10.280 |
52 Wk Range | 4.540 - 16.745 |
Market Cap | $2.342B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 24.47% |
Days to Cover | 6.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Recursion Pharmaceuticals (NASDAQ: RXRX) through any online brokerage.
Other companies in Recursion Pharmaceuticals’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Syndax Pharmaceuticals (NASDAQ:SNDX), TG Therapeutics (NASDAQ:TGTX) and PTC Therapeutics (NASDAQ:PTCT).
The latest price target for Recursion Pharmaceuticals (NASDAQ: RXRX) was reported by Keybanc on Monday, March 4, 2024. The analyst firm set a price target for 16.00 expecting RXRX to rise to within 12 months (a possible 60.32% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $9.98 last updated March 28, 2024 at 7:58 PM EDT.
There are no upcoming dividends for Recursion Pharmaceuticals.
Recursion Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Recursion Pharmaceuticals.
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.